跳至主要内容
临床试验/CTRI/2019/06/019501
CTRI/2019/06/019501尚未招募2 期

ESCALATE: Linezolid As An Add On Treatment In The Intensive Phase Of Tubercular Meningitis-A Randomised Controlled Trial - ESCALATE

Aiims0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
Aiims

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 18 years old or older
  • 2.Willing to participate in the study by signing informed consent
  • 3.Clinically diagnosed as TB meningitis by standard criteria using clinical, CSF and radiological findings

排除标准

  • 1.Failure to perform lumbar puncture
  • 2.HIV positivity
  • 3.Disseminated tuberculosis
  • 4.Proven MDR, XDR TB
  • 5.Confirmed meningitis other than TB
  • 6.On tubercular drug for more than 15 days
  • 7.Current treatment with: MAO inhibitors, direct and indirect acting sympathomimetic drugs
  • 8.Pregnant or lactating female
  • 9.Hepatic insufficiency (ALT >5x upper normal limit)
  • 10.Kidney dysfunction (eGFR <50ml/min)
  • 11.Known hypersensitivity to rifampicin and/or linezolid

研究者

发起方
Aiims

相似试验